PRDM13: A Potential Drug Target and Biomarker for Cell Cycle Regulation

Target Name: PRDM13

NCBI ID: G59336

PRDM13: A Potential Drug Target and Biomarker for Cell Cycle Regulation

PRDM13, also known as PR domain-containing protein 13, is a protein that is expressed in various cell types of the human body. It is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material. PRDM13 plays a vital role in controlling the length of the cell cycle, and is essential for the proper functioning of cells.

Recent studies have suggested that PRDM13 may be a drug target or biomarker, which could be used to develop new treatments for various diseases. One potential mechanism by which PRDM13 could be used as a drug target is its role in the regulation of the cell cycle. By interfering with the cell cycle, PRDM13 has been shown to cause various cellular changes, such as the inhibition of cell division and the regulation of cell size. This suggests that PRDM13 could be used to treat diseases that are characterized by uncontrolled cell growth, such as cancer.

Another potential mechanism by which PRDM13 could be used as a drug target is its role in the regulation of stem cell proliferation. PRDM13 has been shown to regulate the stem cell proliferation cycle, which is the process by which stem cells differentiate into fully-functional cells. This suggests that PRDM13 could be used to treat diseases that are characterized by the uncontrolled proliferation of stem cells, such as leukemia.

In addition to its potential as a drug target, PRDM13 has also been shown to have potential as a biomarker. The cell cycle is a critical regulator of various cellular processes, including the development and progression of cancer. As such, the regulation of the cell cycle has been widely studied as a potential biomarker for cancer. PRDM13 has been shown to be highly expressed in various types of cancer, and has been used as a biomarker for the diagnosis and prognosis of various diseases, including cancer.

Overall, PRDM13 is a protein that has broad implications for the regulation of the cell cycle and has been shown to have potential as a drug target and biomarker. Further research is needed to fully understand the role of PRDM13 in the regulation of the cell cycle and its potential as a drug and biomarker.

Protein Name: PR/SET Domain 13

Functions: May be involved in transcriptional regulation. Is required for the differentiation of KISS1-expressing neurons in the arcuate (Arc) nucleus of the hypothalamus. Is a critical regulator of GABAergic cell fate in the cerebellum, required for normal postnatal cerebellar development (By similarity)

More Common Targets